Atlas Venture is a Cambridge, Massachusetts–based early-stage venture capital firm founded in 1980 that specializes in creating and funding biotechnology startup companies in the United States, deploying seed-led capital and strategic support to translate scientific research into novel medicines and therapeutics; it operates with a science-first, patient-centric approach, partnering with entrepreneurs and researchers to build and scale companies from discovery through clinical development and has contributed to numerous IPOs and acquisitions in the life sciences sector.